Betina Østergaard Eriksen

Vice President, Safety Surveillance at Novo Nordisk
Betina Østergaard Eriksen

Betina Østergaard Eriksen is currently Vice President, Safety Surveillance at Novo Nordisk, where she is responsible for signal management, risk management and aggregate reporting across the product portfolio. She has a broad experience from European and global leadership roles in Alpharma, Nycomed, Takeda and Novo Nordisk covering pharmacovigilance, clinical operations, clinical processes, R&D outsourcing, data management, analytical science and medical information. She has participated in GCP- and PV-inspections by EMA, FDA and many national authorities inside and outside EU. Furthermore, Betina has significant experience with mergers and acquisitions after having a leading role within her area of expertise during several company mergers.

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more